Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
UPADACITINIB | A218866 | AUROBINDO PHARMA LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2025-04-04 | Terminated 2025-09-12 | — | |
AbbVie Inc. v. Aurobindo Pharma USA, Inc. et al 34 patentsANDA 218859, 218866, 218792, 218940, 217611upadacitinib | D. Del. | 2023-11-20 | Terminated 2025-09-12 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.